U. Machein

700 total citations
12 papers, 573 citations indexed

About

U. Machein is a scholar working on Molecular Biology, Surgery and Transplantation. According to data from OpenAlex, U. Machein has authored 12 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Transplantation. Recurrent topics in U. Machein's work include Renal Transplantation Outcomes and Treatments (3 papers), Neurological Complications and Syndromes (3 papers) and Signaling Pathways in Disease (2 papers). U. Machein is often cited by papers focused on Renal Transplantation Outcomes and Treatments (3 papers), Neurological Complications and Syndromes (3 papers) and Signaling Pathways in Disease (2 papers). U. Machein collaborates with scholars based in Germany, United States and Switzerland. U. Machein's co-authors include Walter Conca, H. H. Peter, Márcia Regina Machein, Dieter Platt, Stephan Krieger, Klaus Häger, Joachim Bauer, Lionel Rostaing, Bettina Ulbricht and Bernd L. Fiebich and has published in prestigious journals such as Journal of Neurochemistry, American Journal Of Pathology and Annals of the Rheumatic Diseases.

In The Last Decade

U. Machein

12 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Machein Germany 7 196 156 136 120 117 12 573
Takahisa Noto Japan 17 63 0.3× 66 0.4× 280 2.1× 54 0.5× 66 0.6× 47 636
Davide Scozzi United States 16 61 0.3× 58 0.4× 156 1.1× 44 0.4× 182 1.6× 30 651
Peter J. Chlebeck United States 11 100 0.5× 89 0.6× 69 0.5× 18 0.1× 169 1.4× 22 544
Rongwen Yuan United States 6 27 0.1× 75 0.5× 120 0.9× 28 0.2× 42 0.4× 6 722
Jonathan Canaani Israel 19 29 0.1× 198 1.3× 262 1.9× 72 0.6× 51 0.4× 65 978
Tuncer Onay United States 15 13 0.1× 127 0.8× 406 3.0× 30 0.3× 103 0.9× 23 928
Sara Tezza United States 12 46 0.2× 50 0.3× 147 1.1× 12 0.1× 257 2.2× 17 647
Hasina Outtz Reed United States 10 7 0.0× 108 0.7× 139 1.0× 48 0.4× 98 0.8× 17 512
Jean‐Christophe Zech France 12 20 0.1× 36 0.2× 94 0.7× 17 0.1× 138 1.2× 26 500
Gabriele Schratzberger Austria 7 40 0.2× 35 0.2× 251 1.8× 37 0.3× 61 0.5× 8 510

Countries citing papers authored by U. Machein

Since Specialization
Citations

This map shows the geographic impact of U. Machein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Machein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Machein more than expected).

Fields of papers citing papers by U. Machein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Machein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Machein. The network helps show where U. Machein may publish in the future.

Co-authorship network of co-authors of U. Machein

This figure shows the co-authorship network connecting the top 25 collaborators of U. Machein. A scholar is included among the top collaborators of U. Machein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Machein. U. Machein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
3.
Langer, R.M., Ronald J. Hené, Š Vı́tko, et al.. (2012). Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation. Transplant International. 25(5). 592–602. 98 indexed citations
4.
Holdaas, Hallvard, Lionel Rostaing, Daniel Serón, et al.. (2011). Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study. Transplantation. 92(4). 410–418. 110 indexed citations
5.
Tolba, René H., U. Machein, Thomas Minor, et al.. (2001). Conversion to neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life. Transplantation Proceedings. 33(7-8). 3446–3447. 1 indexed citations
6.
Schumann, Günter, Michael Hüell, U. Machein, Gertrud M. Hocke, & Bernd L. Fiebich. (1999). Interleukin‐6 Activates Signal Transducer and Activator of Transcription and Mitogen‐Activated Protein Kinase Signal Transduction Pathways and Induces De Novo Protein Synthesis in Human Neuronal Cells. Journal of Neurochemistry. 73(5). 2009–2017. 32 indexed citations
7.
Machein, U., et al.. (1998). Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Human Brain Tumors. American Journal Of Pathology. 153(2). 429–437. 156 indexed citations
8.
Machein, U. & Walter Conca. (1997). Expression of Several Matrix Metalloproteinase Genes in Human Monocytic Cells. Advances in experimental medicine and biology. 421. 247–251. 12 indexed citations
9.
Häger, Klaus, et al.. (1996). 173. Interleukin-6 and parameters of haemostasis. Fibrinolysis and Proteolysis. 10. 54–54. 1 indexed citations
10.
Machein, U., Klaus Lieb, Michael Hüll, & Bernd L. Fiebich. (1995). IL-1β and TNFα, but not IL-6, induce α1- antichymotrypsin expression in the human astrocytoma cell line U373 MG. Neuroreport. 6(17). 2283–2286. 22 indexed citations
11.
Häger, Klaus, et al.. (1994). Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiology of Aging. 15(6). 771–772. 137 indexed citations
12.
Machein, U., et al.. (1992). Deletion and insertion mutants of HBsAg particles. PubMed. 4. 133–136. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahisa Noto Breakdown of academic impact, for papers by Davide Scozzi Breakdown of academic impact, for papers by Peter J. Chlebeck Breakdown of academic impact, for papers by Rongwen Yuan Breakdown of academic impact, for papers by Jonathan Canaani Breakdown of academic impact, for papers by Tuncer Onay Breakdown of academic impact, for papers by Sara Tezza Breakdown of academic impact, for papers by Hasina Outtz Reed Breakdown of academic impact, for papers by Jean‐Christophe Zech Breakdown of academic impact, for papers by Gabriele Schratzberger
Rankless by CCL
2026